IMA Active and CONTINUUS Pharmaceuticals examine continuous manufacturing of solid oral dosage forms by integration of Raman spectroscopy to an Extrusion-Molding-Coating (EMC) unit.
Brice Ezzouaouy, senior product manager at Beckman Coulter Life Sciences, looks at the journey of the 2017 IVD Regulation and how it affects different aspects of the industry.
Technology supplier to the life sciences industry Cytiva is opening a new manufacturing facility in Cardiff, Wales as parts of its global expansion plans.
Innovative medicines can bring hope to people with rare diseases – let’s get them to patients, says Paul Catchpole director of Value and Access policy, Association of the British Pharmaceutical Industry.
European Pharmaceutical Manufacturer explores the rise of ketamine as treatment for depression and why a recent study shines hope on the drug being used to treat alcohol use disorder.
Ian Bolland is joined by Martin Gouldstone and Ray Valencia from Sensyne Health to explain more about the use of synthetic control arms, clinical trial transformation, speeding up the process and its SENSIGHT platform – which works within the NHS.
Ashley Fraser and Clara Zacharko, CRA Life Sciences Practice, Toronto look at what revised guidelines to the Patented Medicine Prices Review Board means for drug pricing in Canada.
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic.
Dr Toby Astill, global market manager - Cannabis and Hemp Markets at PerkinElmer, talks about the growth of cannabis in the pharmaceutical industry and the importance of chromatography to this sector.
Dr Pamela Walker, partner and head of life sciences at Gate One, and Anna Sherriff, principal at Gate One discuss how pharma can use digital tools to inform their marketing strategies and create better customer engagement.
